Recent developments of carbonic anhydrase inhibitors as potential anticancer drugs

Journal of Medicinal Chemistry

Volumn 51, Issue 11, 2008, Pages 3051-3056

  Thiry, Anne ^a   Supuran, Claudiu T ^b   Masereel, Bernard ^a   Dogné, Jean Michel ^a  

^a UNIVERSITY OF NAMUR   (Belgium)

^b UNIVERSITY OF FLORENCE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETAZOLAMIDE; ANTINEOPLASTIC AGENT; CARBONATE DEHYDRATASE; CARBONATE DEHYDRATASE I; CARBONATE DEHYDRATASE II; CARBONATE DEHYDRATASE III; CARBONATE DEHYDRATASE INHIBITOR; CARBONATE DEHYDRATASE IV; CARBONATE DEHYDRATASE IX; CARBONATE DEHYDRATASE V; CARBONATE DEHYDRATASE VA; CARBONATE DEHYDRATASE VB; CARBONATE DEHYDRATASE VII; CARBONATE DEHYDRATASE XII; CARBONATE DEHYDRATASE XIII; CARBONATE DEHYDRATASE XIV; CARBONATE DEHYDRATASE XV; ETHOXZOLAMIDE; INDISULAM; METHAZOLAMIDE;

ANTINEOPLASTIC ACTIVITY; CANCER RESEARCH; DRUG RESEARCH; DRUG STRUCTURE; ENZYME INHIBITION; HUMAN; NONHUMAN; SHORT SURVEY;

ANTIGENS, NEOPLASM; ANTINEOPLASTIC AGENTS; BINDING SITES; CARBONIC ANHYDRASE INHIBITORS; CARBONIC ANHYDRASES; CELL HYPOXIA; HUMANS; ISOENZYMES; NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 44949190364     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm701526d     Document Type: Short Survey

References (35)

1. Badger, M. R.; Price, G. D. The role of carbonic anhydrase in photosynthesis. Annu. Rev. Plant Physiol. Plant Mol. Biol. 1994, 45, 369-392.
2. Hilvo, M.; Tolvanen, M.; Clark, A.; Shen, B.; Shah, G. N.; Waheed, A.; Halmi, P.; Hanninen, M.; Hamalainen, J. M.; Vihinen, M.; Sly, W. S.; Parkkila, S. Characterization of CA XV, a new GPI-anchored form of carbonic anhydrase. Biochem. J. 2005, 392, 83-92.
3. Lane, T. W.; Morel, F. M. A biological function for cadmium in marine diatoms. Proc. Natl. Acad. Sci. U.S.A. 2000, 97, 4627-4631.
4. Supuran, C. T. Carbonic Anhydrases: Catalytic and Inhibition Mechanisms, Distribution and Physiological Roles. In Carbonic Anhydrase. Its Inhibitors and Activators; CRC Press: London, 2004; pp 1-23.
5. Supuran, C. T. Carbonic anhydrases as drug targets - an overview. Curr. Top. Med. Chem. 2007, 7, 825-833.
6. Supuran, C. T. Carbonic anhydrases: novel therapeutic applications for inhibitors and activators. Nat. Rev. Drug Discovery, in press.
7. Supuran, C. T.; Scozzafava, A.; Casini, A. Carbonic anhydrase inhibitors. Med. Res. Rev. 2003, 23, 146-189.
8. Thiry, A.; Dogné, J. M.; Masereel, B.; Supuran, C. T. Targeting tumor-associated carbonic anhydrase IX in cancer therapy. Trends Pharmacol. Sci. 2006, 27, 566-573.
9. Pastoreková, S.; Kopacek, J.; Pastorek, J. Carbonic anhydrase inhibitors and the management of cancer. Curr. Top. Med. Chem. 2007, 7, 865-878.
10. Pastoreková, S.; Zavadova, Z.; Kostal, M.; Babusikova, O.; Zavada, J. A novel quasi-viral agent, MaTu, is a two-component system. Virology 1992, 187, 620-626.
11. Pastoreková, S.; Pastorek, J. Cancer-Related Carbonic Anhydrase Isozymes and Their Inhibition. In Carbonic Anhydrase. Its Inhibitors and Activators; CRC Press: London, 2004; 255-281.
12. Svastova, E.; Zilka, N.; Zat'ovicova, M.; Gibadulinova, A.; Ciampor, F.; Pastorek, J.; Pastorekova, S. Carbonic anhydrase IX reduces E-cadherin-mediated adhesion of MDCK cells via interaction with beta-catenin. Exp. Cell Res. 2003, 290, 332-345.
13. Zavada, J.; Zavadova, Z.; Pastorek, J.; Biesova, Z.; Jezek, J.; Velek, J. Human tumour-associated cell adhesion protein MN/CA IX: identification of M75 epitope and of the region mediating cell adhesion. Br. J. Cancer 2000, 82, 1808-1813.
14. Stubbs, M.; McSheehy, P. M.; Griffiths, J. R.; Bashford, C. L. Causes and consequences of tumour acidity and implications for treatment. Mol. Med. Today 2000, 6, 15-19.
15. Svastova, E.; Hulikova, A.; Rafajova, M.; Zat'ovicova, M.; Gibadulinova, A.; Casini, A.; Cecchi, A.; Scozzafava, A.; Supuran, C. T.; Pastorek, J.; Pastorekova, S. Hypoxia activates the capacity of tumor-associated carbonic anhydrase IX to acidify extracellular pH. FEBS Lett. 2004, 577, 439-445.
16. Supuran, C. T. Development of Sulfonamide Carbonic Anhydrase Inhibitors. In Carbonic Anhydrase. Its Inhibitors and Activators; CRC Press: London, 2004; pp 67-147.
17. Supuran, C. T.; Briganti, F.; Tilli, S.; Chegwidden, W. R.; Scozzafava, A. Carbonic anhydrase inhibitors: sulfonamides as antitumor agents? Bioorg. Med. Chem. 2001, 9, 703-714.
18. Supuran, C. T.; Scozzafava, A. Carbonic anhydrase inhibitors - Part 94. 1,3,4-Thiadiazole-2-sulfonamidederivatives as antitumor agents? Eur. J. Med. Chem. 2000, 35, 867-874.
19. Supuran, C. T.; Scozzafava, A. Carbonic anhydrase inhibitors: aromatic sulfonamides and disulfonamides act as efficient tumor growth inhibitors. J. Enzyme Inhib. 2000, 15, 597-610.
20. Parkkila, S.; Rajaniemi, H.; Parkkila, A. K.; Kivela, J.; Waheed, A.; Pastorekova, S.; Pastorek, J.; Sly, W. S. Carbonic anhydrase inhibitor suppresses invasion of renal cancer cells in vitro. Proc. Natl. Acad. Sci. U.S.A. 2000, 97, 2220-2224.
21. Teicher, B. A.; Liu, S. D.; Liu, J. T.; Holden, S. A.; Herman, T. S. A carbonic anhydrase inhibitor as a potential modulator of cancer therapies. Anticancer Res. 1993, 13, 1549-1556.
22. Supuran, C. T. Indisulam: an anticancer sulfonamide in clinical development. Expert Opin. Invest. Drugs 2003, 12, 283-287.
23. Casey, J. R.; Morgan, P. E.; Vullo, D.; Scozzafava, A.; Mastrolorenzo, A.; Supuran, C. T. Carbonic anhydrase inhibitors. Design of selective, membrane-impermeant inhibitors targeting the human tumor-associated isozyme IX. J. Med. Chem. 2004, 47, 2337-2347.
24. Scozzafava, A.; Briganti, F.; Ilies, M. A.; Supuran, C. T. Carbonic anhydrase inhibitors: synthesis of membrane-impermeant low molecular weight sulfonamides possessing in vivo selectivity for the membrane-bound versus cytosolic isozymes. J. Med. Chem. 2000, 43, 292-300.
25. Wilkinson, B. L.; Bornaghi, L. F.; Houston, T. A.; Innocenti, A.; Supuran, C. T.; Poulsen, S. A. A novel class of carbonic anhydrase inhibitors: glycoconjugate benzene sulfonamides prepared by "click-tailing". J. Med. Chem. 2006, 49, 6539-6548.
26. Wilkinson, B. L.; Bornaghi, L. F.; Houston, T. A.; Innocenti, A.; Vullo, D.; Supuran, C. T.; Poulsen, S. A. Carbonic anhydrase inhibitors: inhibition of isozymes I, II, and IX with triazole-linked O-glycosides of benzene sulfonamides. J. Med. Chem. 2007, 50, 1651-1657.
27. De Simone, G.; Vitale, R. M.; Di Fiore, A.; Pedone, C.; Scozzafava, A.; Montera, J. L.; Winum, J. Y.; Supuran, C. T. Carbonic anhydrase inhibitors: hypoxia-activatable sulfonamides incorporating disulfide bonds that target the tumor-associated isoform IX. J. Med. Chem. 2006, 49, 5544-5551.
28. Denny, W. A. Tumor-activated prodrugs - a new approach to cancer therapy. Cancer Invest. 2004, 22, 604-619.
29. Garber, K. New drugs target hypoxia response in tumors. J. Natl. Cancer Inst. 2005, 97, 1112-1114.
30. Welsh, S. J.; Williams, R. R.; Birmingham, A.; Newman, D. J.; Kirkpatrick, D. L.; Powis, G. The thioredoxin redox inhibitors 1-methylpropyl 2-imidazolyl disulfide and pleurotin inhibit hypoxia-induced factor 1alpha and vascular endothelial growth factor formation. Mol. Cancer Ther. 2003, 2, 235-243.
31. Cecchi, A.; Hulikova, A.; Pastorek, J.; Pastorekova, S.; Scozzafava, A.; Winum, J. Y.; Montera, J. L.; Supuran, C. T. Carbonic anhydrase inhibitors. Design of fluorescent sulfonamides as probes of tumor-associated carbonic anhydrase IX that inhibit isozyme IX-mediated acidification of hypoxic tumors. J. Med. Chem. 2005, 48, 4834-4841.
32. Dubois, L.; Douma, K.; Supuran, C. T.; Chiu, R. K.; van Zandvoort, M. A.; Pastorekova, S.; Scozzafava, A.; Wouters, B. G.; Lambin, P. Imaging the hypoxia surrogate marker CA IX requires expression and catalytic activity for binding fluorescent sulfonamide inhibitors. Radiother. Oncol. 2007, 83, 367-373.
33. Alterio, V.; Vitale, R. M.; Monti, S. M.; Pedone, C.; Scozzafava, A.; Cecchi, A.; De Simone, G.; Supuran, C. T. Carbonic anhydrase inhibitors: X-ray and molecular modeling study for the interaction of a fluorescent antitumor sulfonamide with isozyme II and IX. J. Am. Chem. Soc. 2006, 128, 8329-8335.
34. Thiry, A.; Ledecq, M.; Cecchi, A.; Dogne, J. M.; Wouters, J.; Supuran, C. T.; Masereel, B. Indanesulfonamides as carbonic anhydrase inhibitors. Toward structure-based design of selective inhibitors of the tumor-associated isozyme CA IX. J. Med. Chem. 2006, 49, 2743-2749.
35. Winum, J. Y.; Cecchi, A.; Montera, J. L.; Innocenti, A.; Scozzafava, A.; Supuran, C. T. Carbonic anhydrase inhibitors. Synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, and IX with boron-containing sulfonamides, sulfamides, and sulfamates: toward agents for boron neutron capture therapy of hypoxic tumors. Bioorg. Med. Chem. Lett. 2005, 15, 3302-3306.